Patent drop reveals pressures on industry.
作者信息
Lawrence Stacy
出版信息
Nat Biotechnol. 2004 Aug;22(8):930-1. doi: 10.1038/nbt0804-930.
PMID:15286630
Abstract
摘要
相似文献
1
Patent drop reveals pressures on industry.
Nat Biotechnol. 2004 Aug;22(8):930-1. doi: 10.1038/nbt0804-930.
2
Biotech patenting slows in 2004.
Nat Biotechnol. 2005 Oct;23(10):1198. doi: 10.1038/nbt1005-1198.
3
Biotech patenting upturn.
Nat Biotechnol. 2006 Oct;24(10):1190. doi: 10.1038/nbt1006-1190.
4
Patent holdings of US biotherapeutic companies in major markets.
Drug Discov Today. 2009 May;14(9-10):442-5. doi: 10.1016/j.drudis.2009.01.010. Epub 2009 Feb 11.
5
Insights into US public biotech sector using patenting trends.
Nat Biotechnol. 2006 Jun;24(6):643-51. doi: 10.1038/nbt0606-643.
6
Biotech patenting matures.
Nat Biotechnol. 2004 Oct;22(10):1202. doi: 10.1038/nbt1004-1202.
7
Pharmaceutical patent life-cycle management after KSR v. Teleflex.
Food Drug Law J. 2008;63(1):275-320.
8
Biotech as Bush bows out.
Nat Biotechnol. 2008 Jan;26(1):15-8. doi: 10.1038/nbt0108-15.
9
The patentability of antibodies in the United States.
Nat Biotechnol. 2005 Sep;23(9):1079-80. doi: 10.1038/nbt0905-1079.
10
Biotech patents-business as usual?
Nat Biotechnol. 2008 Dec;26(12):1326. doi: 10.1038/nbt1208-1326.
引用本文的文献
1
Trends in genetic patent applications: the commercialization of academic intellectual property.
Eur J Hum Genet. 2014 Oct;22(10):1155-9. doi: 10.1038/ejhg.2013.305. Epub 2014 Jan 22.
Zotero 插件